Publications by authors named "Eva Gross"

Claim this Profile
D
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Eva Gross

Br J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
Daniel R Barnes, Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis, Eva Gross

J Natl Cancer Inst· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.
Sabine Grill, Juliane Ramser, Heide Hellebrand, Nicole Pfarr, Melanie Boxberg

Arch Gynecol Obstet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients.
Xiaocong Geng, Lamiya Babayeva, Axel Walch, Michaela Aubele, Eva Groß

Am J Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis.
Paula Hepp, Laura Unverdorben, Stefan Hutter, Christina Kuhn, Nina Ditsch

Int J Mol Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Michael T Parsons, Emma Tudini, Hongyan Li, Eric Hahnen, Barbara Wappenschmidt, Eva Gross

Hum Mutat· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Put a Ring in It: Exploring Women's Experiences with the Contraceptive Vaginal Ring in Ontario.
Kathryn J LaRoche, Eva Gross, Grace Sheehy, Angel M Foster

Womens Health Issues· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Jan Hauke, Judit Horvath, Eva Groß, Andrea Gehrig, Ellen Honisch

Cancer Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
Magdalena Absmaier, Rudolf Napieralski, Tibor Schuster, Michaela Aubele, Axel Walch, Eva Gross

Int J Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Nana Weber-Lassalle, Jan Hauke, Juliane Ramser, Lisa Richters, Eva Groß

Breast Cancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells.
Julia Miller, Tobias F Dreyer, Anne Sophie Bächer, Eva-Kathrin Sinner, Christine Heinrich, Eva Gross

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.
Guido Neidhardt, Jan Hauke, Juliane Ramser, Eva Groß, Andrea Gehrig

JAMA Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer.
Feng Yang, Michaela Aubele, Axel Walch, Eva Gross, Rudolf Napieralski

Biol Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study.
Eva Gross, Harm van Tinteren, Zhou Li, Sandra Raab, Christina Meul

BMC Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R.
Michaela C Huber, Rebecca Mall, Herbert Braselmann, Annette Feuchtinger, Sara Molatore, Eva Gross

BMC Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.
Didier Meulendijks, Linda M Henricks, Gabe S Sonke, Maarten J Deenen, Tanja K Froehlich, Eva Gross

Lancet Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the devaluation of vulnerable groups: A novel application of Institutional Anomie Theory.
Andreas Hövermann, Eva M Groß, Andreas Zick, Steven F Messner

Soc Sci Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
Sina Upheber, Alexandra Karle, Julia Miller, Stephanie Schlaugk, Eva Gross

Cell Signal· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer.
Anna Lehner, Viktor Magdolen, Tibor Schuster, Matthias Kotzsch, Marion Kiechle, Eva Gross

PLoS One· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mild phenotype of dihydropyrimidine dehydrogenase deficiency and developmental retardation associated with a missense mutation affecting cofactor binding.
Sabine Weidensee, Peter Goettig, Marko Bertone, Dorothea Haas, Viktor Magdolen, Eva Gross

Clin Biochem· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
Heide Hellebrand, Christian Sutter, Ellen Honisch, Eva Gross, Barbara Wappenschmidt

Hum Mutat· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity.
André B P van Kuilenburg, Judith Meijer, Adri N P M Mul, Rutger Meinsma, Veronika Schmid, Eva Gross

Hum Genet· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?
Joseph Ciccolini, Eva Gross, Laetitia Dahan, Bruno Lacarelle, Cédric Mercier

Clin Colorectal Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-onset central hypoventilation presenting as extubation failure.
Malena Cohen-Cymberknoh, David Shoseyov, Shmuel Goldberg, Eva Gross, Jeanne Amiel

Isr Med Assoc J· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
Zlatna Ruseva, Pamina Xenia Charlotte Geiger, Peter Hutzler, Matthias Kotzsch, Birgit Luber, Eva Gross

Exp Cell Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis